Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

M. Ruella; S. S. Kenderian; O. Shestova; M. Klichinsky; J. J. Melenhorst; M. A. Wasik; S. F. Lacey; C. H. June; S. Gill

doi:10.1038/leu.2016.262

Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

M. Ruella, S. S. Kenderian, O. Shestova, M. Klichinsky, J. J. Melenhorst, M. A. Wasik, S. F. Lacey, C. H. June, S. Gill

Research output: Contribution to journal › Letter › peer-review

98 Scopus citations

Original language	English
Pages (from-to)	246-248
Number of pages	3
Journal	Leukemia
Volume	31
Issue number	1
DOIs	https://doi.org/10.1038/leu.2016.262
State	Published - Jan 1 2017
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1038/leu.2016.262

Cite this

@article{79cab338e15d42a09f872827d5630a14,

title = "Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms",

author = "M. Ruella and Kenderian, {S. S.} and O. Shestova and M. Klichinsky and Melenhorst, {J. J.} and Wasik, {M. A.} and Lacey, {S. F.} and June, {C. H.} and S. Gill",

year = "2017",

month = jan,

day = "1",

doi = "10.1038/leu.2016.262",

language = "English",

volume = "31",

pages = "246--248",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Nature Publishing Group",

number = "1",

}

TY - JOUR

T1 - Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

AU - Ruella, M.

AU - Kenderian, S. S.

AU - Shestova, O.

AU - Klichinsky, M.

AU - Melenhorst, J. J.

AU - Wasik, M. A.

AU - Lacey, S. F.

AU - June, C. H.

AU - Gill, S.

PY - 2017/1/1

Y1 - 2017/1/1

UR - http://www.scopus.com/inward/record.url?scp=84990878466&partnerID=8YFLogxK

U2 - 10.1038/leu.2016.262

DO - 10.1038/leu.2016.262

M3 - Letter

C2 - 27677739

AN - SCOPUS:84990878466

SN - 0887-6924

VL - 31

SP - 246

EP - 248

JO - Leukemia

JF - Leukemia

IS - 1

ER -

Kinase inhibitor ibrutinib to prevent cytokine-release syndrome after anti-CD19 chimeric antigen receptor T cells for B-cell neoplasms

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this